David Oh Email & Phone Number

● charter member of first commercial sales force for a previously clinical stage biotech company● helped launch a drug for Parkinson's patients● sold small molecule drug through specialty pharmacy distribution● call points include movement disorder specialists, general neurologists, geriatricians, geriatric psychiatrists, general psychiatrists, pediatric neurologists● 1st year launch top 10 in nation in total number of prescribers● finished #16 out of 109 overall in the nation for 2016● Q1 2017 #1 in nation with special incentive contest for new prescribers● finished #20 out of 103 overall in the nation for 2017● promoted to Executive Neuroscience Sales Specialist from Senior Neuroscience Sales Specialist October 2018 for successful sales performance● ranked #1 in region, #10 in nation 2022● collaborated with Rett rare disease rep counterpart in helping identify 2 new patients for Daybue, Acadia’s treatment for Rett Syndrome. ● Circle of Excellence Winner (President's Club) 2023

• Market primarily to urologists and endocrinologists regarding testosterone replacement therapy; additionally helped launch and market Xiaflex; a biologic, collagenase injectable for Dupuytren’s contracture, as well as for Peyronie’s. In addition to Xiaflex, sold Aveed injectable and Testopel implantable pellets, all buy and bill products.• Winner of the Dump the Pump contest for time period Aug 1st – Oct 31st 2010 awarded to reps with biggest increases in market share.• Ranked #2 in the region 2011• Ranked #1 in the region 2012• Ranked 4th out of 150 in the nation with the new launch of Stendra through first qtr 2014• Promoted to Endo / Innovia division, last remaining Auxilium Primera rep in region, gaining extensive buy and bill experience.• Have experience selling a Risk Evaltuation and Mitigation Strategy (REMS) drug.

• Create marketing initiatives at the hospital and referring physician office level. Host meetings with the hospital marketing staff, including the CEO, CFO, COO, Physician Liaison, VP of marketing, OR director to create a marketing plan utilizing Acclarent’s technologies. • Consultative selling to head and neck surgeons during case coverage of sinus surgeries in the operating room (OR experience).

Successfully marketed an injectible monoclonal antibody to neonatologists and pediatricians at both the hospital and office setting.Gained high level expertise in the coordination of approval for Synagis with IPAs and specialty Pharmacies Synagis: Total Patient Active Status up 65% year on year through Feb. 12, 2009. Ranked #1 out of 263 in the nation.

2007 overall ranked 4th in region; 33rd out of 489 in nation –within top 10% in nation; RUBY AWARD WINNER 2006 Final Winner’s Circle Ranking: o Region Rank 1 of 31 (top 3.2% percentile) o Nation Rank 3 of 574 (top 1% percentile) o 2006 DIAMOND AWARD WINNER; top 1% in region and nation, highest award for GSK employees2005 Final Winner’s Circle Ranking: o Region Rank 6 of 28 (top 21.4% percentile) o Nation Rank 11 of 599 (top 2% percentile) o 2005 RUBY AWARD WINNER – in 1st yr of eligibility, placed in top 20%